Macrogenics Inc (MGNX)
3.81
+0.04
(+1.06%)
USD |
NASDAQ |
Nov 14, 16:00
3.815
0.00 (0.00%)
After-Hours: 20:00
Macrogenics Gross Profit (Annual): 48.97M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 48.97M |
| December 31, 2022 | 142.63M |
| December 31, 2021 | 72.99M |
| Date | Value |
|---|---|
| December 31, 2020 | 97.76M |
| December 31, 2019 | 62.02M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
48.97M
Minimum
2023
142.63M
Maximum
2022
84.88M
Average
72.99M
Median
2021
Gross Profit (Annual) Benchmarks
| KORU Medical Systems Inc | 16.71M |
| Apellis Pharmaceuticals Inc | 338.08M |
| NovaBay Pharmaceuticals Inc | 7.895M |
| Palatin Technologies Inc | 4.392M |
| iBio Inc | -- |